Part of Carl-Zeiss-Stiftung, Carl Zeiss Microscopy GmbH is a German company located in Goettingen that manufactures microscopy products.

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Leica Biosystems Nussloch GmbH, a subsidiary of Danaher Corp., is a company headquartered in Nussloch, Germany. The firm operates as cancer diagnostics company for tackling pathology challenges.\nThe company says this about itself: Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of \"Advancing Cancer Diagnostics, Improving Lives\" is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries and is headquartered in Nussloch, Germany.

Shenzhen Reetoo Biotechnology Co., Ltd. is a Chinese company located in Shenzhen. The firm engages in research & development, production and sale of cell based inspection products.

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

AVE Science & Technology Co., Ltd. engages in the research, development, production, sale, and service of clinical testing and analysis instruments. It offers in vitro diagnostic reagents, urine formation analyzers, urine dry chemical analyzers, automatic urine and stool analyzers, reproductive tract secretion analyzers, and automatic body fluid analyzers. The company was founded by Jian Wen Ding in March 1994 and is headquartered in Changsha, China.

Inner Vision Imaging LLC manufactures medical devices. The company is headquartered in Farmington Hills, MI.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Ebara Corp. engages in the manufacture and sale of industrial machineries. It operates through the following segments: Fluid Machinery and Systems, Environmental Plants, Precision Machinery, and Others. The Fluid Machinery and Systems segment deals with the manufacture, sale, and maintenance of pumps, compressors, turbines, cooling machines, and blowers. The Environmental Plants segment handles engineering, construction, operation, and maintenance of municipal and industrial waste incineration plants and water treatment plants. The Precision Machinery segment manufactures and sells vacuum pumps, plating systems, and exhaust gas treatment equipment. The Others segment includes business support services. The company was founded by Issey Hatakeyama in November 1912 and is headquartered in Tokyo, Japan.

JPKInstruments AG manufactures nanoanalytical instruments. Its products are atomic force microscopy, automated force spectroscopy, optical tweezers and optical trapping, cellular adhesion, and cytomechanics. The company was founded by Torsten Jähnke, Jörn Kamps and Frank Pelzer in October 1999 and is headquartered in Berlin, Germany.

Ernst Leitz Wetzlar GmbH, part of ACM Project Development Co., is a German company located in Wetzlar that designs and manufactures cine lenses. Carsten Schuckenböhmer is currently the CEO of the firm.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, PCB, Display & Component Inspection, and Other. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded in April 1997 and is headquartered in Milpitas, CA.

Chongqing Defang Information Technology Co., Ltd., established on 2018-08-13, Business scope includes licensed projects:Electronics and Intelligent Engineering,Intelligent system engineering,Engaged in the import and export of goods and technology,The second type of value-added telecommunications services,Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Computer software and hardware development,Sales;Computer Information System Integration;Sales:laboratory equipment,purifying facility,computer consumables;Office equipment rental;Information Technology Consulting Services;Network Technology Consulting Services;graphic design(Except for special regulations of the state);make,acting,release:Domestic and foreign advertising;Business Management Consulting(Except for projects requiring permits or approvals),Sales of Class II Medical Devices,Health Consulting Services(Does not include medical services),R&D of sanitary ware,Sanitary Ware Manufacturing,Sanitary Ware Sales,internet sales(Except for products that require a license for sale),Data processing and storage support services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Stepan Co. engages in the manufacture and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers a range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants. The Polymers segment produces polyester polyols and phthalic anhydride. The Specialty Products segment consists of chemicals used in food, flavoring, nutritional supplements, and pharmaceutical applications. The company was founded by Alfred C. Stepan Jr. in 1932 and is headquartered in Northbrook, IL.

Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. The company passionately pursues its mission to improve the lives of all patients afflicted with cancer. Ventana Medical Systems discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number one Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. Ventana Medical Systems is a member of the Roche Group that is drawing on powerful partnerships with world-class scientific institutions.